|Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial|
J Shepherd, GJ Blauw, MB Murphy, ELEM Bollen, BM Buckley, SM Cobbe, ...
The Lancet 360 (9346), 1623-1630, 2002
|Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study|
N Sattar, A Gaw, O Scherbakova, I Ford, DSJ O’Reilly, SM Haffner, C Isles, ...
Circulation 108 (4), 414-419, 2003
|Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study|
DJ Freeman, J Norrie, N Sattar, RDG Neely, SM Cobbe, I Ford, C Isles, ...
Circulation 103 (3), 357-362, 2001
|Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS)|
AM Wallace, AD McMahon, CJ Packard, A Kelly, J Shepherd, A Gaw, ...
Circulation 104 (25), 3052-3056, 2001
|C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study|
DJ Freeman, J Norrie, MJ Caslake, A Gaw, I Ford, GDO Lowe, ...
Diabetes 51 (5), 1596-1600, 2002
|The design of a prospective study of pravastatin in the elderly at risk (PROSPER)|
J Shepherd, GJ Blauw, MB Murphy, SM Cobbe, ELEM Bollen, BM Buckley, ...
The American journal of cardiology 84 (10), 1192-1197, 1999
|Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre‐eclampsia|
N Sattar, A Gaw, CJ Packard, IA Greer
BJOG: An International Journal of Obstetrics & Gynaecology 103 (7), 614-620, 1996
|Clinical Biochemistry E-Book: An Illustrated Colour Text|
A Gaw, M Murphy, R Srivastava, RA Cowan, DSJ O'Reilly
Elsevier Health Sciences, 2013
|Testing cognitive function in elderly populations: the PROSPER study|
PJ Houx, J Shepherd, GJ Blauw, MB Murphy, I Ford, EL Bollen, B Buckley, ...
Journal of Neurology, Neurosurgery & Psychiatry 73 (4), 385-389, 2002
|Association Between Apolipoprotein E4 and Cognitive Decline in Elderly Adults|
CJ Packard, RGJ Westendorp, DJ Stott, MJ Caslake, HM Murray, ...
Journal of the American Geriatrics Society 55 (11), 1777-1785, 2007
|Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia.|
MJ Caslake, CJ Packard, A Gaw, E Murray, BA Griffin, BD Vallance, ...
Arteriosclerosis and thrombosis: a journal of vascular biology 13 (5), 702-711, 1993
|West of Scotland Coronary Prevention Study: C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study|
Diabetes 51, 1596-1600, 2002
|C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)|
N Sattar, HM Murray, A McConnachie, GJ Blauw, ELEM Bollen, ...
Circulation 115 (8), 981-989, 2007
|Effects of simvastatin on apoB metabolism and LDL subfraction distribution.|
A Gaw, CJ Packard, EF Murray, GM Lindsay, BA Griffin, MJ Caslake, ...
Arteriosclerosis and thrombosis: a journal of vascular biology 13 (2), 170-189, 1993
|Comparative analysis of the apo (a) gene, apo (a) glycoprotein, and plasma concentrations of Lp (a) in three ethnic groups. Evidence for no common" null" allele at the apo (a …|
A Gaw, E Boerwinkle, JC Cohen, HH Hobbs
Journal of Clinical Investigation 93 (6), 2526, 1994
|Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and …|
N Sattar, A McConnachie, I Ford, A Gaw, SJ Cleland, NG Forouhi, ...
Diabetes 56 (4), 984-991, 2007
|Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)|
CJ Packard, I Ford, M Robertson, J Shepherd, GJ Blauw, MB Murphy, ...
Circulation 112 (20), 3058-3065, 2005
|Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy …|
LM Blanco-Colio, JL Martín-Ventura, E de Teresa, C Farsang, A Gaw, ...
American heart journal 153 (5), 881-888, 2007
|Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins|
A Gaw, CJ Packard, GM Lindsay, BA Griffin, MJ Caslake, AR Lorimer, ...
Journal of lipid research 36 (1), 158-171, 1995
|Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Atorvastatin on Inflammatory Markers (AIM) study, a substudy of ACTFAST|
LM Blanco-Colio, JL Martín-Ventura, E De Teresa, C Farsang, A Gaw, ...
Arteriosclerosis, thrombosis, and vascular biology 27 (1), 168-174, 2007